Symptomatic Control of Neuroendocrine Tumors with Everolimus

被引：0
|
作者：
Bainbridge, H. [1 ]
Larbi, E. [2 ]
Middleton, G. [2 ]
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Royal Surrey Cty Hosp, Guildford, Surrey, England
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine; carcinoid; everolimus; symptom;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] Inducing, Understanding and Overcoming Resistance to Everolimus in Pancreatic Neuroendocrine Tumors
    Vandamme, T.
    Op de Beeck, K.
    Beyens, M.
    Mortier, G.
    Pauwels, P.
    Van Camp, G.
    De Herder, W.
    Peeters, M.
    Holand, L. J.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 225 - 226
  • [22] Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors
    Raj, Nitya
    Zheng, Youyun
    Hauser, Haley
    Chou, Joanne
    Rafailov, Johnathan
    Bou-Ayache, Jad
    Sawan, Peter
    Chaft, Jamie
    Chan, Jennifer
    Perez, Kimberly
    Rudin, Charles
    Tang, Laura
    Reidy-Lagunes, Diane
    ENDOCRINE-RELATED CANCER, 2021, 28 (04) : 237 - 246
  • [23] Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
    Cen, Putao
    Amato, Robert J.
    ONCOTARGETS AND THERAPY, 2012, 5 : 217 - 224
  • [24] Everolimus treatment for neuroendocrine tumors: latest results and clinical potential
    Pusceddu, Sara
    Verzoni, Elena
    Prinzi, Natialie
    Mennitto, Alessia
    Femia, Daniela
    Grassi, Paolo
    Concas, Laura
    Vernieri, Claudio
    Lo Russo, Giuseppe
    Procopio, Giuseppe
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (03) : 183 - 188
  • [25] Role of Radiomics in the Everolimus response prediction of metastatic neuroendocrine tumors
    Magi, L.
    Polici, M.
    Zerunian, M.
    Rinzivillo, M.
    Marasco, M.
    Iannicelli, E.
    Caruso, D.
    Annibale, B.
    Laghi, A.
    Panzuto, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 129 - 129
  • [26] Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine Tumors
    Thompson, Lisa A.
    Kim, Miryoung
    Wenger, Sarah D.
    O'Bryant, Cindy L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1212 - 1219
  • [27] Evaluation of Everolimus (EVE) in Patients with Metastatic Lung Neuroendocrine Tumors
    Kuznetsova, A.
    Gorbunova, V
    Orel, N.
    Emelianova, G.
    Markovich, A.
    Kolomeytceva, A.
    Fedenko, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 215 - 215
  • [28] Everolimus Cumulative Dose and Dose Intensity in Pancreatic Neuroendocrine Tumors
    Berardi, R.
    Torniai, M.
    Pusceddu, S.
    Spada, F.
    Brizzi, M. P.
    Ibrahim, T.
    Antonuzzo, L.
    Ferolla, P.
    Panzuto, F.
    Silvestris, N.
    Partelli, S.
    Bongiovanni, A.
    Zichi, C.
    Riva, N.
    Rinzivillo, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 77 - 77
  • [29] Opportunist Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study
    Mauro, C.
    De Jesus, V
    Nunez, J. E.
    Costa, F.
    Barros, M.
    Riechelmann, R.
    NEUROENDOCRINOLOGY, 2019, 108 : 173 - 173
  • [30] Everolimus and Transarterial Embolization (TAE) for Hepatic Metastasis in Neuroendocrine Tumors (NET)
    Chauhan, Aman
    Waits, Tim
    El Khouli, Riham
    Krohmer, Steven
    Anthony, Lowell
    PANCREAS, 2019, 48 (03) : 431 - 431
12345